B-CULTURE is a pioneering startup offering 4D drug testing technology and customized solutions to Pharma, Cosmetic Industries, CRO's, and Academia. Founded in 2019 and headquartered in Portugal, the company is spearheading advanced technology and services for drug testing. Its innovative approach provides a reliable and animal-friendly alternative to traditional in vitro methods for drug screening. B-CULTURE's 4D solutions are designed to closely mimic the human body, offering a superior product to currently available screening methods. The company's custom solutions are tailored to meet the specific needs of the Pharma and Cosmetic Industries, as well as CRO's and Academia. B-CULTURE was founded by a group of experienced professionals with diverse backgrounds, aiming to address their own research needs through cutting-edge technological advancements. The company serves a global market, ranging from leading Pharma and Cosmetics firms to prestigious academic institutions and esteemed CROs. B-CULTURE employs a 'razor&blade' entry business model and plans to introduce screening services over time. While the last investment details are not available, the company's cutting-edge technology and tailored solutions position it as a compelling prospect for potential investment in the future.
There is no investment information
No recent news or press coverage available for B-CULTURE.